Advertisement
UK markets close in 7 hours 47 minutes
  • FTSE 100

    8,425.53
    +44.18 (+0.53%)
     
  • FTSE 250

    20,596.95
    +65.65 (+0.32%)
     
  • AIM

    785.68
    +1.98 (+0.25%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.10%)
     
  • GBP/USD

    1.2530
    +0.0006 (+0.05%)
     
  • Bitcoin GBP

    50,450.73
    +1,463.25 (+2.99%)
     
  • CMC Crypto 200

    1,359.82
    +1.81 (+0.13%)
     
  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     
  • DOW

    39,387.76
    +331.36 (+0.85%)
     
  • CRUDE OIL

    79.75
    +0.49 (+0.62%)
     
  • GOLD FUTURES

    2,373.90
    +33.60 (+1.44%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,969.45
    +431.64 (+2.33%)
     
  • DAX

    18,774.53
    +87.93 (+0.47%)
     
  • CAC 40

    8,222.52
    +34.87 (+0.43%)
     

Performance of AstraZeneca’s Oncology Segment in 3Q17

AstraZeneca’s (AZN) Oncology segment reported revenues of ~$1 billion during 3Q17, a 19% growth at constant exchange rates.